271 related articles for article (PubMed ID: 16525186)
41. CNS tumors: supportive management of the patient and family.
Wegmann JA
Oncology (Williston Park); 1991 Nov; 5(11):109-13; discussion 113-4, 116. PubMed ID: 1837226
[TBL] [Abstract][Full Text] [Related]
42. [The First Step in a Long-Run-Celebrating the announcement of "Guideline for the management of CNS gliomas in China"].
Zhou LF
Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2417. PubMed ID: 24300261
[No Abstract] [Full Text] [Related]
43. [Central Nervous System Tumor Additional Therapies for Gliomas].
Yamaguchi F
Gan To Kagaku Ryoho; 2018 Jun; 45(6):921-922. PubMed ID: 30026414
[No Abstract] [Full Text] [Related]
44. Feasibility of conducting long-term follow-up of children and infants treated for CNS tumors on the same cooperative group clinical trial protocol.
Hoag J; Kupst MJ; Briere ME; Mabbott D; Elkin TD; Trask CL; Isenberg J; Holm S; Ambler C; Strother DR
J Clin Psychol Med Settings; 2014 Jun; 21(2):136-43. PubMed ID: 24668336
[TBL] [Abstract][Full Text] [Related]
45. Malignant gliomas in 2005: where to GO from here?
Fisher PG; Buffler PA
JAMA; 2005 Feb; 293(5):615-7. PubMed ID: 15687318
[No Abstract] [Full Text] [Related]
46. The beautiful and ethereal neurological exam: an appeal for research.
Johnston SC; Hauser SL
Ann Neurol; 2011 Aug; 70(2):A9-A10. PubMed ID: 21823150
[No Abstract] [Full Text] [Related]
47. Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors.
Armstrong TS; Gilbert MR
Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S30-S38. PubMed ID: 34725696
[TBL] [Abstract][Full Text] [Related]
48. Comment on: Effects of surgery on neurocognitive function in patients with glioma: a meta-analysis of immediate post-operative and long-term follow-up neurocognitive outcomes.
Rijnen SJM; Sitskoorn MM; Gehring K
J Neurooncol; 2019 May; 143(1):175-176. PubMed ID: 30859484
[No Abstract] [Full Text] [Related]
49. Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors.
Noll KR; Bradshaw ME; Parsons MW; Dawson EL; Rexer J; Wefel JS
Curr Treat Options Neurol; 2019 Jun; 21(7):33. PubMed ID: 31250277
[TBL] [Abstract][Full Text] [Related]
50. Central nervous system tumours lack national studies.
Eden OB
Arch Dis Child; 1994 Nov; 71(5):482. PubMed ID: 7826128
[No Abstract] [Full Text] [Related]
51. Central nervous system tumours lack national studies.
Thorne R; Foreman NK
Arch Dis Child; 1994 Jul; 71(1):95-6. PubMed ID: 8067805
[No Abstract] [Full Text] [Related]
52. Refining endpoints in brain tumor clinical trials.
Meyers CA; Rock EP; Fine HA
J Neurooncol; 2012 Jun; 108(2):227-30. PubMed ID: 22451194
[TBL] [Abstract][Full Text] [Related]
53. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy.
Crossen JR; Garwood D; Glatstein E; Neuwelt EA
J Clin Oncol; 1994 Mar; 12(3):627-42. PubMed ID: 8120563
[TBL] [Abstract][Full Text] [Related]
54. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.
Brown PD; Pugh S; Laack NN; Wefel JS; Khuntia D; Meyers C; Choucair A; Fox S; Suh JH; Roberge D; Kavadi V; Bentzen SM; Mehta MP; Watkins-Bruner D;
Neuro Oncol; 2013 Oct; 15(10):1429-37. PubMed ID: 23956241
[TBL] [Abstract][Full Text] [Related]
55. Strategies for preservation of memory function in patients with brain metastases.
Dye NB; Gondi V; Mehta MP
Chin Clin Oncol; 2015 Jun; 4(2):24. PubMed ID: 26112810
[TBL] [Abstract][Full Text] [Related]
56. Molecular pathways: radiation-induced cognitive impairment.
Greene-Schloesser D; Moore E; Robbins ME
Clin Cancer Res; 2013 May; 19(9):2294-300. PubMed ID: 23388505
[TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety evaluation of combined therapies incorporating whole-brain radiotherapy in patients with brain metastases: a systematic review and meta-analysis.
Yan Q; Li R; Yang J; Bai X; Guo X; Yang X; Song J
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38789890
[TBL] [Abstract][Full Text] [Related]
58. Terminally differentiated cytotoxic CD4
Ma X; Zuo Y; Hu X; Chen S; Zhong K; Xue R; Gui S; Liu K; Li S; Zhu X; Yang J; Deng Z; Liu X; Xu Y; Liu S; Shi Z; Zhou M; Tang Y
CNS Neurosci Ther; 2024 Mar; 30(3):e14682. PubMed ID: 38499993
[TBL] [Abstract][Full Text] [Related]
59. Pituitary neuroendocrine tumor: A neuropsychological comparison with intra-axial tumor.
Tang H; Fang Y; Bie Z; Jia H; Wang B; Yang Z; Yang R; Gao Z; Wang X; Liu P
Ann Clin Transl Neurol; 2024 Apr; 11(4):1021-1033. PubMed ID: 38385869
[TBL] [Abstract][Full Text] [Related]
60. "Non-Eloquent" brain regions predict neuropsychological outcome in tumor patients undergoing awake craniotomy.
Chohan MO; Flores RA; Wertz C; Jung RE
PLoS One; 2024; 19(2):e0284261. PubMed ID: 38300915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
